Pharming Group N.V. (PHAR)
NASDAQ: PHAR · Real-Time Price · USD
12.98
-0.01 (-0.08%)
Jun 1, 2026, 1:20 PM EDT - Market open
Pharming Group Market Cap
Pharming Group has a market cap or net worth of $949.84 million as of June 1, 2026. Its market cap has increased by 29.26% in one year.
Market Cap
949.84M
Enterprise Value
895.17M
1-Year Change
29.26%
Ranking
Category
Stock Price
$12.98
Market Cap Chart
Since June 16, 1999, Pharming Group's market cap has increased from $128.85M to $949.84M, an increase of 637.14%. That is a compound annual growth rate of 7.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 29, 2026 | 949.84M | -17.20% |
| Dec 31, 2025 | 1.15B | 76.58% |
| Dec 31, 2024 | 649.63M | -14.84% |
| Dec 29, 2023 | 762.86M | 0.93% |
| Dec 30, 2022 | 755.82M | 32.18% |
| Dec 31, 2021 | 571.80M | -42.41% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cullinan Therapeutics | 1.01B |
| MeiraGTx Holdings | 986.29M |
| Alpha Tau Medical | 976.61M |
| Lexicon Pharmaceuticals | 968.35M |
| Seaport Therapeutics | 964.58M |
| Sana Biotechnology | 918.36M |
| Kura Oncology | 905.50M |
| Arbutus Biopharma | 900.77M |